Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3603)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2023 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kayikcioglu E, Yüceer RO, Cetin B, Yüceer K, Karahan N. Prognostic value of claudin 18.2 expression in gastric adenocarcinoma. World J Gastrointest Oncol 2023; 15(2): 343-351 [PMID: 36908327 DOI: 10.4251/wjgo.v15.i2.343] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i2/343.htm |
| Number | Citing Articles |
| 1 |
Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara. Claudin 18.2 as a novel therapeutic target. Nature Reviews Clinical Oncology 2024; 21(5): 354 doi: 10.1038/s41571-024-00874-2
|
| 2 |
Jun Wu, Jinghua Lu, Qiuyue Chen, Haojie Chen, Yongqiang Zheng, Minggang Cheng. Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1494131
|
| 3 |
Su Ir Lyu, Caroline Fretter, Adrian Georg Simon, Sarah-Michele Spielmann, Alexander I. Damanakis, Yue Zhao, Christiane J. Bruns, Thomas Schmidt, Felix C. Popp, Dirk Waldschmidt, Alexander Quaas, Karl Knipper. Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence. Translational Oncology 2024; 47: 102044 doi: 10.1016/j.tranon.2024.102044
|
| 4 |
Eugene Choi, Jinho Shin, Min-Hee Ryu, Hyung-Don Kim, Young Soo Park. Heterogeneity of claudin 18.2 expression in metastatic gastric cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68411-w
|
| 5 |
Francisco Cezar Aquino de Moraes, Luis Eduardo Rodrigues Sobreira, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodríguez Burbano. The role of CLDN18.2 in gastric cancer prognosis: a systematic review and meta-analysis. Biomarkers 2024; 29(8): 528 doi: 10.1080/1354750X.2024.2422965
|
| 6 |
Hongyan Yin, Rongkui Luo, Jing Lv, Wujian Mao, Hongcheng Shi. Relationship between [18F]FDG PET/CT findings and claudin 18.2 expression in metastatic gastric cancer. European Radiology 2024; doi: 10.1007/s00330-024-11186-5
|
| 7 |
Aynur IŞIK, Güneş GÜNER, Can ZEYNELOĞLU, Seçil DEMİRKOL CANLI, Hakki TASTAN, Aytekin AKYOL. Claudin 18.2 Expression in Gastric Adenocarcinomas in a Large Turkish Cohort. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi 2023; 12(2): 5 doi: 10.47493/abantmedj.1313791
|
| 8 |
Akira Matsuishi, Shotaro Nakajima, Motonobu Saito, Katsuharu Saito, Satoshi Fukai, Hideaki Tsumuraya, Ryo Kanoda, Tomohiro Kikuchi, Azuma Nirei, Akinao Kaneta, Hirokazu Okayama, Kosaku Mimura, Hiroyuki Hanayama, Wataru Sakamoto, Tomoyuki Momma, Zenichiro Saze, Koji Kono. The impact of CLDN18.2 expression on effector cells mediating antibody-dependent cellular cytotoxicity in gastric cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68970-y
|
| 9 |
Xiao-Yu Wang, De-Fan Yao, Gang Ren. Progress in research of tumor biomarkers and molecular imaging probes for gastric cancer. World Chinese Journal of Digestology 2024; 32(1): 1 doi: 10.11569/wcjd.v32.i1.1
|
| 10 |
Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva, Renata D’Alpino Peixoto. Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?. Cancers 2024; 16(3): 679 doi: 10.3390/cancers16030679
|
| 11 |
Fangqian Du, Yuwei Xie, Shengze Wu, Mengling Ji, Bingzi Dong, Chengzhan Zhu. Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases. Journal of Hepatocellular Carcinoma 2024; : 1801 doi: 10.2147/JHC.S483861
|